About Our Company
Protheragen is a specialized radiopharmaceutical CRDMO and CRO platform dedicated to accelerating the development of targeted radiotherapies and molecular imaging agents. We integrate end-to-end capabilities spanning drug discovery, preclinical evaluation, IIT clinical trials, and cGMP manufacturing — enabling our partners to transform novel targeting concepts into clinical-ready radiopharmaceuticals with speed, precision, and regulatory confidence.
Protheragen is a full-service radiopharmaceutical platform combining CRO discovery and CRDMO manufacturing under one roof. We support every stage of your program — from target identification and radiolabeling to IIT execution and commercial cGMP supply — so you can move faster with fewer handoffs and complete accountability.
Discovery Services
Preclinical Research Services
IIT Clinical Services
Molecular Imaging CRO Services
Radiochemical Services
Quality Research Services
IND Enabling Services
Clinical Supply Services
Commercial Scale cGMP Production Services
Radionuclide Supply & Supply Chain Services
Project Management & Support Services
WORKING TOGETHER
At our company, we value collaborative partnerships that drive innovation and progress in the field of radiopharmaceutical development.
To accelerate the development of life-changing radiopharmaceuticals by delivering integrated discovery, clinical, and manufacturing solutions that transform targeted cancer therapies from concept to patient.
We partner with our clients with unwavering quality, regulatory rigor, and operational transparency — ensuring every radiopharmaceutical we touch advances safely, swiftly, and successfully toward improving patient outcomes.